Menu Search
Equities

Aster DM Healthcare Ltd

ASTERDM:NSI

Aster DM Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)439.30
  • Today's Change7.05 / 1.63%
  • Shares traded2.04m
  • 1 Year change+30.41%
  • Beta1.2299
Data delayed at least 15 minutes, as of Nov 25 2024 10:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy3
Outperform3
Hold1
Sell0
Strong Sell0

Share price forecast in INR

The 7 analysts offering 12 month price targets for Aster DM Healthcare Ltd have a median target of 490.00, with a high estimate of 520.00 and a low estimate of 435.00. The median estimate represents a 11.36% increase from the last price of 440.00.
High18.2%520.00
Med11.4%490.00
Low-1.1%435.00

Dividends

In 2024, Aster DM Healthcare Ltd reported a dividend of 2.00 INR. The 3 analysts covering the company expect dividends of 118.63 INR for the upcoming fiscal year, an increase of 5,831.65%.
Div growth (TTM)--
More ▼

Earnings history & estimates in INR

On Oct 23, 2024, Aster DM Healthcare Ltd reported 2nd quarter 2025 earnings of 1.94 per share. This result exceeded the 1.60 expectation of the one analyst covering the company and exceeded last year's 2nd quarter results by 1.46.
The next earnings announcement is expected on May 26, 2025.
Average growth rate+340.54%
Aster DM Healthcare Ltd reported annual 2024 earnings of 3.70 per share on May 28, 2024.
Average growth rate+32.60%
More ▼

Revenue history & estimates in INR

Aster DM Healthcare Limited had 2nd quarter 2025 revenues of 10.86bn. This bettered the 10.70bn consensus of the 3 analysts covering the company. This was 66.21% below the prior year's 2nd quarter results.
Average growth rate-13.05%
Aster DM Healthcare Limited had revenues for the full year 2024 of 139.78bn. This was 17.14% above the prior year's results.
Average growth rate+12.79%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.